Population Pharmacokinetics of Teduglutide Following Repeated Subcutaneous Administrations in Healthy Participants and in Patients with Short Bowel Syndrome and Crohn’s Disease Publication Population Pharmacokinetics of Teduglutide Following Repeated Subcutaneous Administrations in Healthy Participants and in Patients with Short Bowel Syndrome and Crohn’s Disease Teduglutide is a GLP-2 analog currently evaluated for the treatment of short bowel syndrome, Crohn's…Certara2010年1月1日
Prediction of Human Drug and Drug Interactions from Time-dependent Inactivation of CYP3A4 in Primary Hepatocytes Using a Population-based Simulator Publication Prediction of Human Drug and Drug Interactions from Time-dependent Inactivation of CYP3A4 in Primary Hepatocytes Using a Population-based Simulator Time-dependent inactivation (TDI) of human cytochromes P450 3A4 (CYP3A4) is a major cause of clinical…Certara2009年12月1日
Assessment of Inter-individual Variability in Predicted Phenytoin Clearance Publication Assessment of Inter-individual Variability in Predicted Phenytoin Clearance The objective of this study was to assess the inter-individual variability in phenytoin (PHT) clearance…Certara2009年12月1日
Clinical Trial Simulations in Pediatric Patients Using Realistic Covariates: Application to Teduglutide, a Glucagon-like Peptide-2 Analog in Neonates and Infants with Short-bowel Syndrome Publication Clinical Trial Simulations in Pediatric Patients Using Realistic Covariates: Application to Teduglutide, a Glucagon-like Peptide-2 Analog in Neonates and Infants with Short-bowel Syndrome Teduglutide, a synthetic glucagon-like peptide-2 (GLP-2) analog with activity relating to the regeneration, maintenance, and…Certara2009年12月1日
Pre-clinical Assessment of the Absorption, Distribution, Metabolism, and Excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an Orally Bioavailable Systemic Hedgehog Signaling Pathway Inhibitor Publication Pre-clinical Assessment of the Absorption, Distribution, Metabolism, and Excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an Orally Bioavailable Systemic Hedgehog Signaling Pathway Inhibitor GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide) is a potent, selective Hedgehog (Hh) signalling pathway inhibitor being developed for the…Certara2009年11月1日
Is a Thorough QTc Study Necessary? The Role of Modeling and Simulation in Evaluating the QTc Prolongation Potential of Drugs Publication Is a Thorough QTc Study Necessary? The Role of Modeling and Simulation in Evaluating the QTc Prolongation Potential of Drugs Concentration-QT (C-QT) modeling has been conducted for multiple compounds at various stages of development in…Certara2009年11月1日
Understanding CYP2D6 Interactions Publication Understanding CYP2D6 Interactions Owing to the polymorphic nature of CYP2D6, clinically significant issues can arise when drugs rely…Certara2009年10月1日
Prediction of Phase 1 Single-dose Pharmacokinetics Using Recombinant Cytochromes P450 and Physiologically-based Modeling Publication Prediction of Phase 1 Single-dose Pharmacokinetics Using Recombinant Cytochromes P450 and Physiologically-based Modeling 1. Ten compounds from the Merck Research Laboratories pipeline were selected to evaluate the utility…Certara2009年9月1日
In Vitro Inhibition of Multiple Cytochrome P450 Isoforms by Xanthone Derivatives from Mangosteen Extract Publication In Vitro Inhibition of Multiple Cytochrome P450 Isoforms by Xanthone Derivatives from Mangosteen Extract Mangosteen is a xanthone-containing fruit found in Southeast Asia for which health claims include maintaining healthy immune…Certara2009年9月1日
Model-based Prediction of Phase 3 Overall Survival in Colorectal Cancer on the Basis of Phase 2 Tumor Dynamics Publication Model-based Prediction of Phase 3 Overall Survival in Colorectal Cancer on the Basis of Phase 2 Tumor Dynamics We developed a drug-disease simulation model to predict antitumor response and overall survival in phase…Certara2009年9月1日